AI-generated summary
The authors report a single-arm phase II trial of 50 patients with locally advanced head and neck cancer receiving radiation and chemotherapy, with photobiomodulation given during treatment. Severe oral mucositis occurred in 11 of 47 analyzed patients (23%), which the authors compare favorably with historical controls. The study had no concurrent control group, so the comparison is with historical data only.
- Participants
- 47
- Who or what was studied
- Adults aged 18 or older with locally advanced head and neck squamous cell carcinoma (excluding oral cavity) receiving definitive or adjuvant radiation with platinum-based chemotherapy
- Limits stated in the abstract
- Single-arm design compared against historical controls rather than a concurrent control group, with a modest sample of 47 analyzed patients.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Oral mucositis, GRADE, Confidence interval, Primary outcome, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.